Omnicell Signs Agreement with Bupa Care Homes to Acquire UK-Based SurgiChem Limited; Terms Undisclosed
December 09, 2013 at 08:04 AM EST
Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of medication and supply management solutions to healthcare systems, today announced that it has signed an agreement with Bupa Care Homes (CFG) plc to purchase the entire outstanding share capital of SurgiChem Limited, a wholly-owned subsidiary of Bupa, for £12,000,000 subject